Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation
Celso Arrais‐Rodrigues(Hotel Dieu Hospital), Vanderson Rocha(Université Paris Cité), Denis Taveira(Hotel Dieu Hospital), Mohamad Mohty(Inserm), Enric Carreras(Hospital Clínic de Barcelona), Marcos de Lima(The University of Texas MD Anderson Cancer Center), Jaime Sanz(Memorial Sloan Kettering Cancer Center), Claudio G. Brunstein(Hotel Dieu Hospital), Éliane Gluckman(Université Paris Cité), Guillermo Sanz(Instituto de Salud Carlos III), Anna Sureda(Institut Català d'Oncologia), Peter Dreger(Heidelberg University), John E. Wagner(NHS Blood and Transplant), Marc Renaud(Hotel Dieu Hospital), Bernard Rio(Hotel Dieu Hospital), Jean‐Luc Harousseau, Sabine Fürst(Hotel Dieu Hospital), Christopher Dalley(Hotel Dieu Hospital), Mitchell S. Cairo(New York Medical College)
Cited by 202
Related Papers
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
|Nature|2010|1.3k
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
|New England Journal of Medicine|2020|859
International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
|Leukemia|2008|808